Cold Chain Platform’s CEO, Linda Kim, interviews Hedley Rees on Cell and Gene Therapy Supply Chain

Some real supply chain writings again!

Turning back to my roots

Today, I’m turning back to my roots in professional management of biopharmaceutical supply chains. C19 has been so all-absorbing, that I’d forgotten what it was like to write for people trying to achieve meaningful ends in the industry—yes, they do exist.

This article was first published in Cold Chain Platform, based in South Kore…